Dopamine vs noradrenaline: inverted-U effects and ADHD theories
- PMID: 19153917
- DOI: 10.1080/00048670802607238
Dopamine vs noradrenaline: inverted-U effects and ADHD theories
Abstract
The aim of the present study was to review the dopamine theory of attention-deficit-hyperactivity disorder (ADHD), in light of recent use of noradrenergic therapies. A historical review of pharmacological theories of ADHD was conducted, including inverted-U, spatial working memory and neural circuit aspects. Pharmacological advances, including animal and human studies of dopaminergic and noradrenergic mechanisms at the prefrontal cortex (PFC), indicate that alpha-2A adrenoreceptor stimulation results in increased dendritic firing during delay periods for preferred directions, while moderate levels of D1 receptor stimulation result in reduction of delay-related firing to non-preferred directions, allowing representational control in the PFC. Recent studies of the COMT val/met gene and stimulant medication response may help explain variation in inverted-U responses in individuals. Further studies utilizing delay-related firing paradigms should be useful in the investigation of attentional syndromes, and responses to newer pharmacological treatments.
Similar articles
-
Mechanism of action of agents used in attention-deficit/hyperactivity disorder.J Clin Psychiatry. 2006;67 Suppl 8:32-8. J Clin Psychiatry. 2006. PMID: 16961428 Review.
-
Mechanism of action of alpha 2A-adrenergic agonists in attention-deficit/hyperactivity disorder with or without oppositional symptoms.J Clin Psychiatry. 2010 Mar;71(3):223-4. doi: 10.4088/JCP.09bs05899pur. J Clin Psychiatry. 2010. PMID: 20331927 No abstract available.
-
Catecholamine influences on dorsolateral prefrontal cortical networks.Biol Psychiatry. 2011 Jun 15;69(12):e89-99. doi: 10.1016/j.biopsych.2011.01.027. Epub 2011 Apr 13. Biol Psychiatry. 2011. PMID: 21489408 Free PMC article. Review.
-
What do dopamine transporter and catechol-o-methyltransferase tell us about attention deficit-hyperactivity disorder? Pharmacogenomic implications.Aust N Z J Psychiatry. 2007 Jan;41(1):10-6. doi: 10.1080/00048670601050432. Aust N Z J Psychiatry. 2007. PMID: 17464676 Review.
-
Effects of methylphenidate on the catecholaminergic system in attention-deficit/hyperactivity disorder.J Clin Psychopharmacol. 2008 Jun;28(3 Suppl 2):S46-53. doi: 10.1097/JCP.0b013e318173312f. J Clin Psychopharmacol. 2008. PMID: 18480677 Review.
Cited by
-
Adolescence methylphenidate treatment in a rodent model of attention deficit/hyperactivity disorder: dopamine transporter function and cellular distribution in adulthood.Biochem Pharmacol. 2013 Jul 15;86(2):309-16. doi: 10.1016/j.bcp.2013.04.013. Epub 2013 Apr 23. Biochem Pharmacol. 2013. PMID: 23623751 Free PMC article.
-
Effect of methylphenidate treatment during adolescence on norepinephrine transporter function in orbitofrontal cortex in a rat model of attention deficit hyperactivity disorder.J Neurosci Methods. 2015 Aug 30;252:55-63. doi: 10.1016/j.jneumeth.2015.02.002. Epub 2015 Feb 11. J Neurosci Methods. 2015. PMID: 25680322 Free PMC article.
-
Defining the interconnectivity of the medial prefrontal cortex and ventral midbrain.Front Mol Neurosci. 2022 Jul 22;15:971349. doi: 10.3389/fnmol.2022.971349. eCollection 2022. Front Mol Neurosci. 2022. PMID: 35935333 Free PMC article. Review.
-
Behavioral and neurochemical effects of proline.Metab Brain Dis. 2011 Sep;26(3):159-72. doi: 10.1007/s11011-011-9246-x. Epub 2011 Jun 4. Metab Brain Dis. 2011. PMID: 21643764 Review.
-
Combined Stimulant and Guanfacine Administration in Attention-Deficit/Hyperactivity Disorder: A Controlled, Comparative Study.J Am Acad Child Adolesc Psychiatry. 2016 Aug;55(8):657-666.e1. doi: 10.1016/j.jaac.2016.05.015. Epub 2016 Jun 3. J Am Acad Child Adolesc Psychiatry. 2016. PMID: 27453079 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous